[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$650million Graphic $650million

Investment sees significant interest. Market analysts are optimistic about the potential returns, as indicated by recent social media activity.

About $650million

A financial investment opportunity.

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XX -XX%
1-Year High: XXXXX on 2025-06-03
1-Year Low: X on 2025-06-22

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-08-04
1-Year Low: X on 2025-05-15

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $650million in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-08-04
1-Year Low: X on 2025-05-15

Top assets mentioned In the posts about $650million in the last XX hours

Cytokinetics Inc. (CYTK)

Top topics mentioned In the posts about $650million in the last XX hours

tax bracket, $cytk, debt, make a, investment, kenya

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Kenyan a Guyanese national and their businesses have been indicted for conspiring against the US to illegally divert US-funded global health commodities valued at $650million (Sh84.1 billion) from the Kenya Medical Supplies Authority (KEMSA)"
X Link @dericsay 2025-10-04T05:25Z 6557 followers, XX engagements

"$CYTK (Cytokinetics) is spotlighted by a $XXX million convertible senior notes offering at XXXX% interest maturing in 2031. Convertible notes allow the company to raise capital inexpensively while giving investors the option to convert debt into shares which can ease dilution concerns and signal confidence in growth factors that may help drive the stock higher. The FDA is expected to make a decision on Aficamten by December XX 2025 which could be pivotal for the company's growth trajectory"
X Link @Hello_Investing 2025-09-29T12:11Z XX followers, XXX engagements

"@TheAusInstitute A PNG rugby league team cost the tax payer $650million at least league is real"
X Link @padders001 2025-08-25T11:20Z 6004 followers, XXX engagements